BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Male Breast Cancer Global Alliance - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://mbcglobalalliance.org
X-WR-CALDESC:Events for The Male Breast Cancer Global Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251024T100000
DTEND;TZID=America/New_York:20251025T160000
DTSTAMP:20260417T145743
CREATED:20250916T203255Z
LAST-MODIFIED:20250916T204056Z
UID:6918-1761300000-1761408000@mbcglobalalliance.org
SUMMARY:Fall 2025 Medical Summit
DESCRIPTION:October 24\, 2025\n10:00am – 10:45am\nNaomi Litchfield\nDirector\, Patient Advocacy Bionical Emas\n“Why is Early Access Important to the Breast Cancer Community” \nEarly access is a lifeline for the breast cancer community—delivering faster diagnoses\, life-saving treatments\, and greater survival odds. It means catching cancer when it’s most curable\, easing the burden of harsh therapies\, and giving every patient a fighting chance. \n10:45am – 11:30am\nJose Pablo Leone\, PhD\nDirector\, Program for Breast Cancer in Men\nAssistant Professor of Medicine\, Harvard Medical School / Dana-Farber Cancer Institute\n“Update on the ETHAN Clinical Trial” \nThe ETHAN Clinical Trial at Dana-Farber Cancer Institute advances groundbreaking research for breast cancer in men\, addressing a critical gap in oncology. This program explores tailored treatments\, improves understanding of male-specific disease patterns\, and paves the way for targeted\, life-saving therapies. \n11:30am – 11:45am\nBREAK \n11:45am – 12:30pm\nRobert Bard\, MD\nMedical Director of Bard Diagnostics\n“Image Guided Treatment of Male Breast Cancer Tumors” \nRevolutionizing male breast cancer care—image guidance pinpoints tumors with precision\, attacking cancer while protecting healthy tissue. This cutting-edge approach means fewer side effects\, greater accuracy\, and a powerful step toward personalized therapies that give men stronger outcomes and renewed hope for survival. \n12:30pm – 1:15pm\nCharlotte Bayala\nHost of The Cancer Caregiver Podcast\, Corporate Caregiver Wellness Program Designer\, Speaker\n“Before the Results: How to Stay Grounded When You Can’t Know What’s Coming” \nThis thoughtful tour offers caregivers guidance on staying grounded amid uncertainty. Drawing from the cancer journey\, it highlights resilience\, presence\, and self-care strategies—empowering caregivers to navigate the unknown with steadiness\, compassion\, and strength while supporting loved ones through unpredictable challenges. \n1:15pm – 2:00pm\nErling Donnelly\nVice President\, US Breast Cancer Franchise & Portfolio Marketing Lead\, Pfizer\n“Pfizer’s use of Real World Evidence to support the expansion of Ibrance for use in males and a look ahead.” \nIn today’s advancing cancer landscape\, Pfizer’s use of Real World Evidence (RWE) is reshaping access to Ibrance for men with breast cancer. Attendees will discover its regulatory impact\, clinical significance\, and the forward-looking role of RWE in transforming oncology therapies. \n2:00pm – 2:15pm\nBREAK \n2:15pm – 3:00pm\nDr. Leslie Waltke\nPhysical therapist with a clinical mastery in cancer rehabilitation\, Founder of the Waltke Cancer Rehabilitation Academy\n“The Male Breast Cancer Rehab Plan: easing side effects\, minimizing risks and getting strong again” \nThis presentation showcases how image-guided therapy is transforming male breast cancer care—bringing unmatched precision\, targeted tumor control\, and reduced side effects. Attendees will discover how this innovation drives personalized treatment\, improves survival\, and offers new hope for men battling breast cancer. \n3:00pm – 3:45pm\nDr. Barbara Bartlik\nIntegrative Psychiatrist\n“The Emotional Impact of Male Breast Cancer and its Treatment: Comprehensive Solutions to an Overlooked Problem” \nMale breast cancer carries profound emotional challenges that remain largely unrecognized in healthcare. Exploring the psychological toll of diagnosis and treatment\, this session highlights comprehensive strategies—mental health care\, family support\, and integrative approaches—to foster resilience\, healing\, and improved quality of life. \n\nOctober 25\, 2025\n10:00am – 10:45am\nFatima Cardoso\, MD\, MSc\, FESMO\nSenior Consultant\, Medical Oncology\nPresident ABC Global Alliance\n“Management of Advanced/Metastatic Breast Cancer in Male Patients” \nIn today’s evolving landscape of cancer care\, men with advanced or metastatic breast cancer face unique challenges often overshadowed by female-focused research. Dr. Fatima Cardoso delivers groundbreaking strategies in management\, therapies\, and compassionate care to transform outcomes and advance male-specific oncology. \n10:45am – 11:30am\nEllen Schupper\nExecutive Director – ABCD – After Breast Cancer Diagnosis\n“The Role of Male Breast Cancer Mentors” \nAmid growing recognition of male breast cancer\, mentorship emerges as a lifeline of hope. Ellen Schupper explores how trained peer mentors empower men with guidance\, emotional support\, and shared experience—bridging isolation and fostering resilience through every stage of diagnosis and survivorship. \n11:30am – 11:50am\nBREAK \n12:00pm – 12:45pm\nDon Dizon\, MD\nJane F. Desforges Chair in Hematology and Oncology and Professor of Medicine\, Tufts University\nChief\, Hematology and Oncology Service Line\, Tufts Medicine\n“Thriving and Palliative Care; What it is and is Not” \nIn an era redefining survivorship\, thriving with cancer requires clarity on palliative care’s true purpose. Dr. Don Dizon challenges misconceptions\, illustrating how palliative care empowers patients—enhancing quality of life\, dignity\, and resilience while advancing beyond outdated views of end-of-life treatment. \n12:25pm – 1:30pm\nBen Park\, MD\nBenjamin F. Byrd\, Jr. Chair in Oncology\nDirector\, Vanderbilt-Ingram Cancer Center\nProfessor of Medicine\, Vanderbilt University Medical Center\n“Circulating Tumor DNA in Early Stage Breast Cancer; Breast Friends Don’t Keep Secrets” \nAs precision medicine reshapes oncology\, circulating tumor DNA offers powerful insight into early-stage breast cancer. This session reveals how ctDNA testing uncovers hidden disease\, guides treatment decisions\, and transforms transparency in care—proving that breast friends don’t keep secrets when survival is at stake. \n1:30pm – 2:15pm\nAngela Mazza\, DO\nTriple board-certified in Endocrinology\, Diabetes and Metabolism\, Internal Medicine\, and Anti-aging and Regenerative Medicine\n“Hormones and Male Cancers” \nIn the evolving fight against men’s cancers\, hormones play a pivotal yet often misunderstood role. Dr. Angela Mazza unpacks the endocrine influences driving cancer risk and progression\, offering groundbreaking insights that bridge prevention\, precision treatment\, and regenerative approaches for improved outcomes. \n  \nWITH YOUR HOST\, CHERI AMBROSE\nFounder and CEO of the Male Breast Cancer Global Alliance (MBCGA) \nCheri Ambrose has become one of the world’s most influential voices in the fight against men’s cancers. A tireless advocate\, she has built an international consortium of survivors\, caregivers\, and medical professionals to confront the biases\, knowledge gaps\, and inequities surrounding male breast cancer. Her leadership has not only elevated the visibility of this rare disease but has also inspired research collaborations\, legislative progress\, and global educational campaigns that continue to save lives. In hosting this 2025 symposium\, Ms. Ambrose represents and unites the expertise of twelve distinguished speakers\, each bringing groundbreaking insights from oncology\, endocrinology\, rehabilitation\, imaging\, and survivorship care. Together\, they highlight the most pressing frontiers in male breast cancer: from early access to life-saving therapies and the use of circulating tumor DNA for precision detection\, to image-guided tumor treatment\, integrative rehab strategies\, and palliative care redefined as a pathway to thriving. By convening this gathering of global experts\, she continues to advance the Alliance’s core mission: education\, advocacy\, and the relentless pursuit of equity in cancer care.
URL:https://mbcglobalalliance.org/event/fall-2025-medical-summit/
ATTACH;FMTTYPE=image/png:https://mbcglobalalliance.org/wp-content/uploads/2025/09/medsum-1-scaled.png
END:VEVENT
END:VCALENDAR